Adrenergic modulation of splenic macrophage cytokine release in polymicrobial sepsis.
Enhanced adrenergic stimulation and catecholamine release are important components of the pathophysiology of sepsis. Under physiological conditions, adrenergic stimulation has been shown to be a negative regulator of proinflammatory cytokine production through increasing IL-10 production. Here we have investigated if adrenergic stimulation similarly inhibits TNF-alpha and IL-6 production by splenic macrophages isolated from a polymicrobial sepsis model. Male B(6)D(2)F(1) mice were subjected to sham (S), laparotomy (Lap), and cecal ligation and puncture (CLP) under anesthesia. Splenic macrophages were isolated 72 h after the initial injury and were stimulated with endotoxin (LPS) in the presence and absence of epinephrine. Compared with S and Lap, splenic macrophages from the CLP group produced significantly less TNF-alpha and IL-6 and more IL-10 when stimulated with LPS. Macrophage cultures from CLP animals incubated with either epinephrine or IL-10 for 2 h had significantly reduced TNF-alpha and IL-6 release in response to LPS. However, similar cultures pretreated with IL-10 antibody before the addition of exogenous epinephrine failed to reverse the attenuation of LPS-stimulated cytokines. Pretreatment of macrophage cultures with beta(2)- (ICI-118551) but not beta(1)-adrenergic (atenolol) receptor antagonists reversed the epinephrine-mediated cytokine attenuation following LPS treatment. Data are also presented that demonstrate the involvement of protein kinase A activation with adrenergic agonist but not with IL-10 stimulation. Taken together, these findings suggest that adrenergic mechanisms may influence peripheral tissue macrophage inflammatory cytokine response following trauma and sepsis, independent of the effects of IL-10.
Deng
Jiangping
J
Department of Physiology, Loyola University Medical Center, 2160 South First Avenue, Maywood, IL 60153, USA.
Muthu
Kuzhali
K
Gamelli
Richard
R
Shankar
Ravi
R
Jones
Stephen B
SB
D000322:Adrenergic Agonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D002478:Cells, Cultured; D017868:Cyclic AMP-Dependent Protein Kinases / Q000187:drug effects / Q000378:metabolism; D016207:Cytokines / Q000187:drug effects / Q000378:metabolism* / Q000494:pharmacology; D004195:Disease Models, Animal; D004731:Endotoxins / Q000494:pharmacology; D004789:Enzyme Activation / Q000502:physiology; D004837:Epinephrine / Q000378:metabolism*; D008262:Macrophage Activation / Q000187:drug effects / Q000502:physiology; D008264:Macrophages / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D051379:Mice; D018805:Sepsis / Q000276:immunology / Q000503:physiopathology*; D013154:Spleen / Q000276:immunology* / Q000378:metabolism
D000322:Adrenergic Agonists; D000319:Adrenergic beta-Antagonists; D016207:Cytokines; D004731:Endotoxins; D017868:Cyclic AMP-Dependent Protein Kinases; D004837:Epinephrine